跳至主要内容
临床试验/EUCTR2010-024543-33-NL
EUCTR2010-024543-33-NL进行中(未招募)不适用

Can memantine prevent memory impairment induced by MDMA in humans - Memantine-MDMA

Maastricht University0 个研究点开始时间: 2011年1月11日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Recreational MDMA users (used at least 3 times of which at least once during the previous year, and maximally 200 times)
  • Age between 18 and 40 years
  • Free from psychotropic medication
  • Good physical health as determined by medical examination and laboratory analysis
  • Absence of any major medical, endocrine and neurological condition
  • Normal weight, body mass index (weight/height2) between 18.5 and 28 kg/m2
  • Written Informed Consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • History of drug abuse (other than the use of MDMA) or addiction
  • Pregnancy or lactation
  • Excessive drinking (> 20 alcoholic consumptions a week)
  • Hypertension (diastolic> 90; systolic> 140)
  • Current or history of psychiatric disorder
  • Liver dysfunctioning
  • (Serious) side effects to previous MDMA use
  • History of cardiac dysfunctions (arrhythmia, ischemic heart disease,…)
  • For women: no use of a reliable contraceptive

研究者

相似试验